Call for Abstracts (Oral/Poster)
WFSBP 2018 KOBE Organizing Committee encourages all interested individuals to attend the congress and to submit abstracts for oral and/or poster presentation.
Abstract submissions should be made through the Online Abstract Submission System on this website.
Submission Date
| January 15, 2018 to | |
Abstract Submission was closed.
How to submit abstracts
All abstract submissions must be made electronically through the Online Abstract Submission System.
E-mails and abstracts not submitted through the Submission System will not be accepted.
- The abstract text should not exceed 300 words (excluding the Title, Authors and Affiliations)
- The text of the abstract should be structured as follows: Objectives - Methods - Results – Conclusions
- References need to be given in the text.
- The title text should not exceed 20 words.
- The full title should be provided, no abbreviations.
- Up to 10 authors and 20 affiliations may be included on each abstract.
- Graphics and tables cannot be submitted as part of your abstract.
- Submitting authors are responsible for proofreading before submission.
- All abstracts should be ethically appropriate for submission.
- If the content infringes upon patients' personal information, informed consent must be obtained from the patient and/or their guardians and the presentation must carefully avoid identifying any individuals. We prohibit presentations that include information, such as hospitalization dates or age that could be used to identify individuals.
- All abstracts will be published online in the scientific program of the WFSBP Congress.
Abstract Topics
| 01 | Addictive Disorders | 32 | Neuroprogression |
|---|---|---|---|
| 02 | ADHD | 33 | Nutritional Psychiatry and the Microbiome |
| 03 | Antidepressants: Basic / Clinical | 34 | Obsessive-Compulsive Disorders: Basic / Clinical |
| 04 | Antipsychotics: Basic / Clinical | 35 | Pain: Basic / Clinical |
| 05 | Anxiety Disorders: Basic / Clinical | 36 | Panic Disorders: Basic / Clinical |
| 06 | Anxiolytics: Basic / Clinical | 37 | Personality Disorders: Basic / Clinical |
| 07 | Bipolar Disorders: Basic / Clinical | 38 | Pharmacoeconomics |
| 08 | Childhood & Adolescent Disorders: Basic / Clinical | 39 | Pharmacogenetics |
| 09 | Chronobiology and Psychiatry | 40 | Placebo / Nocebo |
| 10 | Cognitive Neuroscience | 41 | Post Traumatic Stress Disorders |
| 11 | Consultation and Liaison Psychiatry | 42 | Precision Psychiatry |
| 12 | Dementia: Basic / Clinical | 43 | Pregnancy, Postpartum and Newborn – Mental Health Issues |
| 13 | Depression: Basic / Clinical | 44 | Premenstrual Syndrome: Basic / Clinical |
| 14 | Drug Development | 45 | Psychogeriatrics |
| 15 | Eating Disorders: Basic / Clinical | 46 | Psychoneuroimmunology |
| 16 | Emergency Psychiatry | 47 | Psycho-Oncology |
| 17 | Epidemiology | 48 | Psychopathology |
| 18 | Ethics in Biological Psychiatry | 49 | Psychopharmacology |
| 19 | Forensic Psychiatry | 50 | Psychosurgery |
| 20 | Genetics | 51 | Psychotherapy: Biological Mechanisms |
| 21 | Hypnotics: Basic / Clinical | 52 | Schizophrenia and other psychosis: Basic/Clinical |
| 22 | Light therapy | 53 | Sexual Disorders: Basic / Clinical |
| 23 | Machine Learning and Big Data | 54 | Sleep Disorders: Basic / Clinical |
| 24 | Mental Retardation or Chromosomal Aberrations: Basic / Clinical | 55 | Somatoform Disorders: Basic / Clinical |
| 25 | Molecular Neurobiology | 56 | Stem Cells and Organoids |
| 26 | Mood Stabilisers: Basic / Clinical | 57 | Stimulation Methods (e.g. ECT, TMS, VNS, DBS) |
| 27 | Neuroendocrinology | 58 | Stress: Basic / Clinical |
| 28 | Neuroimaging: Genetic, Functional, Structural | 59 | Suicide: Basic / Clinical |
| 29 | Neuropathology | 60 | Violence: Basic / Clinical |
| 30 | Neurophysiology | 61 | Miscellaneous |
| 31 | Neuroplasticity |
